Literature DB >> 9780253

Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion.

A K Iversen1, L Fugger, J Eugen-Olsen, U Balslev, T Jensen, S Wahl, J Gerstoft, J I Mullins, P Skinhoj.   

Abstract

Forty human immunodeficiency virus type 1 (HIV-1)-infected women participated in a cross-sectional study of possible correlations between chemokine receptor (CCR5 and/or CCR2B) genotype, HIV-1 RNA and DNA load, and beta-chemokine levels (RANTES, MIP-1alpha, MIP-1beta) in blood and cervix. HIV-1 nucleic acid and beta-chemokines were found in all patient blood samples and in more than half of the cervical samples regardless of CCR5 or CCR2B genotype. High beta-chemokine concentrations were in general associated with high virus loads in blood and cervix. In the blood, the proviral DNA load was significantly correlated with the MIP-1alpha concentration, whereas the DNA load in cervix was significantly associated with the MIP-1beta concentration. The cervical viral RNA load was significantly associated with levels of all three chemokines. Thus, when HIV-1 shedding was highest in the genital tract, it was associated with other combinations of beta-chemokines than virus load in blood, suggesting that local immune reactions strongly influence virus load in the cervical compartment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780253     DOI: 10.1086/314433

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Macrophage inflammatory protein 1alpha inhibits postentry steps of human immunodeficiency virus type 1 infection via suppression of intracellular cyclic AMP.

Authors:  Carol-Ann Amella; Barbara Sherry; David H Shepp; Helena Schmidtmayerova
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group.

Authors:  P Baron; J Bremer; S S Wasserman; M Nowicki; B Driscoll; B Polsky; A Kovacs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

3.  Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Authors:  Christine Mauck; Pai-Lien Chen; Charles S Morrison; Raina N Fichorova; Cynthia Kwok; Tsungai Chipato; Robert A Salata; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-26       Impact factor: 2.205

4.  Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding.

Authors:  F Zara; R E Nappi; R Brerra; R Migliavacca; R Maserati; A Spinillo
Journal:  Sex Transm Infect       Date:  2004-04       Impact factor: 3.519

5.  Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.

Authors:  Carey Farquhar; Thomas C VanCott; Dorothy A Mbori-Ngacha; Lena Horani; Rose K Bosire; Joan K Kreiss; Barbra A Richardson; Grace C John-Stewart
Journal:  J Infect Dis       Date:  2002-09-20       Impact factor: 5.226

6.  Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus.

Authors:  Marta E Bull; Gerald H Learn; Scott McElhone; Jane Hitti; David Lockhart; Sarah Holte; Joan Dragavon; Robert W Coombs; James I Mullins; Lisa M Frenkel
Journal:  J Virol       Date:  2009-04-01       Impact factor: 5.103

7.  Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.

Authors:  Patricia Kissinger; Angela Amedee; Rebecca A Clark; Jeanne Dumestre; Katherine P Theall; Leann Myers; Michael E Hagensee; Thomas A Farley; David H Martin
Journal:  Sex Transm Dis       Date:  2009-01       Impact factor: 2.830

8.  Endobiont viruses sensed by the human host - beyond conventional antiparasitic therapy.

Authors:  Raina N Fichorova; Yujin Lee; Hidemi S Yamamoto; Yuko Takagi; Gary R Hayes; Russell P Goodman; Xenia Chepa-Lotrea; Olivia R Buck; Ryan Murray; Tomasz Kula; David H Beach; Bibhuti N Singh; Max L Nibert
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility.

Authors:  Brandon L Walter; Andrew E Armitage; Stephen C Graham; Tulio de Oliveira; Peter Skinhøj; E Yvonne Jones; David I Stuart; Andrew J McMichael; Bruce Chesebro; Astrid Kn Iversen
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.